
Medical Weight Loss Program in Alexandria, VA
Provider-supervised weight loss with GLP-1 therapy (Semaglutide, Tirzepatide, Oral Wegovy and Rybelsus), Phentermine, and prescription medications. Board-certified nurse practitioner serving Alexandria, Arlington, Springfield, Lorton, and Northern Virginia.
Why Is Obesity So Difficult to control?
Obesity is a complex, chronic medical condition influenced by biological, psychological, environmental, and genetic factors. It is not a matter of willpower or personal weakness—it's the result of how the body regulates hunger, hormones, energy use, and metabolism over time.
Prescription Weight Loss Medications - Alexandria VA
FDA-approved medications prescribed by our board-certified nurse practitioner
GLP-1 AGONIST
Rybelsus/Wegovy (Oral)
Daily oral medication for appetite control without injections. Most popular in Alexandria VA.
—5-15% body weight reduction —No injections required
—Long-term management
APPETITE SUPPRESSANT
Phentermine
Proven appetite suppressant for jump-starting weight loss with medical supervision.
—Boosts energy & metabolism —Reduces hunger, long acting
—Short-term use (6-8 months)
COMBINATION
Contrave
Dual-action formula for emotional and reward-driven eating patterns.
—Addresses cravings
—5-10% weight loss
—Gradual dose escalation
INSULIN SENSITIZER
Metformin
Improves insulin sensitivity for patients with metabolic concerns or prediabetes.
—Supports metabolic health
—Aids appetite regulation
—Well-studied safety profile
ANTI-CRAVING
Topiramate
Reduces binge eating behaviors and impulse cravings in combination protocols.
—Binge eating reduction
—Impulse control
—Careful titration
APPETITE CONTROL
Phendimetrazine
Alternative appetite suppressant for moderate obesity management.
—Promotes fullness
—Medical supervision
—Alternative to phentermine
—Take 30 min before meal
DUAL GIP/GLP-1 AGONIST
Tirzepatide (Zepbound)
Dual-action injectable targeting both GIP/GLP-1 receptors for enhanced appetite control and blood sugar regulation.
—20-25% weight reduction
—Weekly injection
—Superior to semaglutide
—Addresses insulin resistance
